In selecting IL-6, TNF-alpha, and hsCRP for our study—markers traditionally associated with chronic inflammation [39]—we hypothesized these biomarkers, along with metabolic syndrome [17] as an inflammation-associated condition, could be instrumental in the underpinnings of both ovarian and cardiometabolic decline. The gene discussed is IL6; the disease is metabolic syndrome.